Drug Injury Lawyer Blog

Any printer or all-in one (print-copy-fax) machine purchased within the last few years comes with its own software to install on your computer. This software includes updates regarding the amount of ink or toner remaining in the cartridge and provides reminders and warnings to replace your ink or toner cartridge as soon as a certain level is reached. However, recent tests have found that these indicators are requiring consumers to change or replace their cartridges before it is truly necessary, thereby wasting ink, toner, and consumers' money.

Continue reading " Unnecessary Replacement of Ink/Toner Cartridges Costing Consumers $$ " »

As we reported here in May, the NY Attorney General filed suit against two debt consolidation firms in New York alleging fraudulent and deceptive business practices. Namely, the companies reportedly charge exorbitant consolidation fees while failing to ever eliminate any of the customer's debt. The result for the customer is greater debt and a damaged credit score. Following up on this growing trend last night, ABC News attempted to get answers to the questions that many consumers would like to know. However, the VP of operations for Credit Solutation of America claimed to be ignorant on many issues.

Continue reading " Credit Solutions Unable to Explain Failures " »

On July 16, 2009, the FDA announced that it has begun a safety review of Genentech's asthma drug Xolair (omalizumab) after reports of an increased risk of heart attack, abnormal heart rhythm, heart failure, and stroke. The Xolair safety review was prompted by interim results from an ongoing study of 5,000 patients with allergic asthma, in which half of the patients took Xolair and half did not. The early results showed a "disproportionate increase" in certain cardiovascular and cerebrovascular problems in patients treated with Xolair.

Continue reading " Risks of Heart Attack and Stroke with Asthma Drug Xolair " »

On August 11, 2009, the British Medical Journal published an article detailing the results of a study aimed at measuring the association between modern antidepressants (Prozac, Paxil, Zoloft, Celexa, Lexapro, etc.) and increased suicidal thinking and conduct. August 11, 2009 BMJ Article

Continue reading " SSRIs and the Suicidality Risk: Class Numbers Belie a Deeper Story " »

On August 4, 2009, the Food and Drug Administration stated that it had completed its analysis of tumor necrosis factor (TNF) blockers and has concluded that there is an increased risk of lymphoma and other cancers associated with the use of these drugs in children and adolescents. Therefore, the FDA said that a new cancer-related warning will be added to the black boxed warning that’s already on this category of drugs, which includes Remicade, Enbrel, Cimzia, Simponi, and Humira. Additionally, the FDA is requiring that the warning also be modified to specifically reflect the occurrence of leukemia and new-onset psoriasis in patients of all ages being treated with TNF blockers. The current boxed warning only alerts users to a risk of serious infections that can be fatal.

Continue reading " FDA Warns of Cancer Risks with TNF Blockers " »

The following products have experienced problems resulting in their recall:

13-foot Square Trampolines. The straps supporting the top of the trampoline’s enclosure to the poles can fail. The enclosure could drop if these straps break, posing a fall risk. Skywalker Holdings LLC, (866) 603-5867 or www.skywalkertrampolines.com

2005 Novara Trionfo Bicycles. The fork can separate from the steerer tube, which can cause the rider to lose control. Recreational Equipment Inc. (REI), (800) 426-4840 or www.rei.com

Continue reading " Recent Consumer Product Recalls " »

On Tuesday, August 4, 2009, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing to debate a bill known as S.540 – the Medical Device Safety Act of 2009.

Continue reading " Preemption Update: Medical Device Safety Act Hearing Before Senate HELP Commmittee " »

Going green is great – just don’t get scammed in the process.

On Monday, July 27, 2009, the Obama Administration’s Car Allowance Rebate System (CARS) – affectionately dubbed “Cash-for-Clunkers” – went into effect. The program incentivizes consumers to purchase newer, fuel-efficient cars by offering cash vouchers in exchange for gas-gazzling trade-ins.

Continue reading " Cash-for-Clunkers Scams " »

Recently, the FDA advised consumers to stop using Zicam intranasal products, including Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs, and Zicam Cold Remedy Swabs (Kids Size). These products contain the active ingredient zinc gluconate and are manufactured by Matrixx Initiatives, Inc., which had been marketing and selling the products as over-the-counter homeopathic cold remedies.

Continue reading " Zicam Causing Loss of Smell? " »

On July 29, 2009, the FDA reported a voluntary recall of the dietary supplement “Steam,” which is manufactured and sold by Nutracoastal Trading, LLC. FDA Safety Summary.

Continue reading " Steam Dietary Supplement Recall " »